chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dizziness, Feeling abnormal, Impaired driving ability, Nausea
Clinical narrative: very shaky; cannot even drive; feeling funny; Anxiety; Do not know what is happening today, they feel light headed here and there, they were fine before and were able to drive, but now unable to even drive.; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (very shaky), IMPAIRED DRIVING ABILITY (cannot even drive), FEELING ABNORMAL (feeling funny), ANXIETY (Anxiety) and DIZZINESS (Do not know what is happening today, they feel light headed here and there, they were fine before and were able to drive, but now unable to even drive.) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for Anxiety.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (very shaky), IMPAIRED DRIVING ABILITY (cannot even drive), FEELING ABNORMAL (feeling funny), ANXIETY (Anxiety), DIZZINESS (Do not know what is happening today, they feel light headed here and there, they were fine before and were able to drive, but now unable to even drive.) and NAUSEA (nauseous). At the time of the report, TREMOR (very shaky), IMPAIRED DRIVING ABILITY (cannot even drive), FEELING ABNORMAL (feeling funny), ANXIETY (Anxiety), DIZZINESS (Do not know what is happening today, they feel light headed here and there, they were fine before and were able to drive, but now unable to even drive.) and NAUSEA (nauseous) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medications included vitamins. Treatment information was not provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: very shaky; cannot even drive; feeling funny; Anxiety; Do not know what is happening today, they feel light headed here and there, they were fine before and were able to drive, but now unable to even drive.; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (very shaky), IMPAIRED DRIVING ABILITY (cannot even drive), FEELING ABNORMAL (feeling funny), ANXIETY (Anxiety) and DIZZINESS (Do not know what is happening today, they feel light headed here and there, they were fine before and were able to drive, but now unable to even drive.) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for Anxiety.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (very shaky), IMPAIRED DRIVING ABILITY (cannot even drive), FEELING ABNORMAL (feeling funny), ANXIETY (Anxiety), DIZZINESS (Do not know what is happening today, they feel light headed here and there, they were fine before and were able to drive, but now unable to even drive.) and NAUSEA (nauseous). At the time of the report, TREMOR (very shaky), IMPAIRED DRIVING ABILITY (cannot even drive), FEELING ABNORMAL (feeling funny), ANXIETY (Anxiety), DIZZINESS (Do not know what is happening today, they feel light headed here and there, they were fine before and were able to drive, but now unable to even drive.) and NAUSEA (nauseous) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medications included vitamins. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Illness
Clinical narrative: Diarrhea; Sick like a dog; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and ILLNESS (Sick like a dog) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea) and ILLNESS (Sick like a dog). At the time of the report, DIARRHOEA (Diarrhea) and ILLNESS (Sick like a dog) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Chills, Fatigue, Hair texture abnormal
Clinical narrative: Anxiety; Sleeplessness; Malaise; Hair started coming in curly; Body aches; Fatigue; Chills; Nasuea; Myalgia in lower back/myalgia in gluteus area; Hip pain; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), INSOMNIA (Sleeplessness), MALAISE (Malaise), HAIR TEXTURE ABNORMAL (Hair started coming in curly) and PAIN (Body aches) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Anxiety), INSOMNIA (Sleeplessness), MALAISE (Malaise), HAIR TEXTURE ABNORMAL (Hair started coming in curly), PAIN (Body aches), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nasuea), MYALGIA (Myalgia in lower back/myalgia in gluteus area) and ARTHRALGIA (Hip pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; Physical therapy for Myalgia and Physical therapy for Arthralgia. At the time of the report, ANXIETY (Anxiety), INSOMNIA (Sleeplessness), MALAISE (Malaise), PAIN (Body aches), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (Nasuea) had resolved, HAIR TEXTURE ABNORMAL (Hair started coming in curly) outcome was unknown and MYALGIA (Myalgia in lower back/myalgia in gluteus area) and ARTHRALGIA (Hip pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Lab reports include CT scan, bone scan and blood work.   No concomitant product information was provided.   This case was linked to MOD-2021-306477 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Malaise, Myalgia, Nausea, Pain
Clinical narrative: Anxiety; Sleeplessness; Malaise; Hair started coming in curly; Body aches; Fatigue; Chills; Nasuea; Myalgia in lower back/myalgia in gluteus area; Hip pain; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), INSOMNIA (Sleeplessness), MALAISE (Malaise), HAIR TEXTURE ABNORMAL (Hair started coming in curly) and PAIN (Body aches) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Anxiety), INSOMNIA (Sleeplessness), MALAISE (Malaise), HAIR TEXTURE ABNORMAL (Hair started coming in curly), PAIN (Body aches), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nasuea), MYALGIA (Myalgia in lower back/myalgia in gluteus area) and ARTHRALGIA (Hip pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; Physical therapy for Myalgia and Physical therapy for Arthralgia. At the time of the report, ANXIETY (Anxiety), INSOMNIA (Sleeplessness), MALAISE (Malaise), PAIN (Body aches), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (Nasuea) had resolved, HAIR TEXTURE ABNORMAL (Hair started coming in curly) outcome was unknown and MYALGIA (Myalgia in lower back/myalgia in gluteus area) and ARTHRALGIA (Hip pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Lab reports include CT scan, bone scan and blood work.   No concomitant product information was provided.   This case was linked to MOD-2021-306477 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Incorrect route of product administration, Pain in extremity, Pyrexia
Clinical narrative: Arm pain; Fever; Injection was not given intramuscularly but rather in a blood vessel; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Injection was not given intramuscularly but rather in a blood vessel) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Systemic) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Injection was not given intramuscularly but rather in a blood vessel). At the time of the report, PAIN IN EXTREMITY (Arm pain) and PYREXIA (Fever) outcome was unknown and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Injection was not given intramuscularly but rather in a blood vessel) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Systemic) was unknown.       No Concomitant medication information was reported. No treatment medications were provided.   Reporter did not allow further contact
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Vestibular disorder, Walking aid user
Clinical narrative: Vestibular disorder; Had to start walking with a cane; This spontaneous case was reported by a consumer and describes the occurrence of VESTIBULAR DISORDER (Vestibular disorder) and WALKING AID USER (Had to start walking with a cane) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 616M20A, 039K20A and 052E21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VESTIBULAR DISORDER (Vestibular disorder) (seriousness criterion disability) and WALKING AID USER (Had to start walking with a cane) (seriousness criterion disability). At the time of the report, VESTIBULAR DISORDER (Vestibular disorder) and WALKING AID USER (Had to start walking with a cane) outcome was unknown.            No concomitant medication reported. No treatment information was provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. It's unclear if this immunocompromised patient had an underlying vestibular disorder, which got exaggerated per the source document. Further information would be requested.   This case was linked to MOD-2021-306534 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. It's unclear if this immunocompromised patient had an underlying vestibular disorder, which got exaggerated per the source document. Further information would be requested.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 358 patients received potentially expired vaccines; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (358 patients received potentially expired vaccines) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A, 038C21A and 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (358 patients received potentially expired vaccines). At the time of the report, EXPIRED PRODUCT ADMINISTERED (358 patients received potentially expired vaccines) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment reported.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Mass
Clinical narrative: She had a lump about half-inch in diameter for about a week.; Chills for 45 minutes; This spontaneous case was reported by a consumer and describes the occurrence of MASS (She had a lump about half-inch in diameter for about a week.) and CHILLS (Chills for 45 minutes) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A, 004M20A and 062E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MASS (She had a lump about half-inch in diameter for about a week.) and CHILLS (Chills for 45 minutes). At the time of the report, MASS (She had a lump about half-inch in diameter for about a week.) and CHILLS (Chills for 45 minutes) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The consumer stated that she took the second dose a little while ago, but so far nothing treatment received, as far as relief for the fever.  No concomitant product use was provided by the reporter.   No treatment medications were reported.   This case was linked to MOD-2021-306542 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 2nd dose administered to patient from Expired vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from Expired vial) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from Expired vial). On 01-Sep-2021, EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from Expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported. The treatment information was not provided  Nurse reported that one of her facilities gave 10 doses between 8AM - 12 PM on 01/Sep/2021 from a Moderna vial that expired on 31/Aug/2021..  It was a new vial that had never been opened. It had been moved into the refrigerator on 25/Aug/2021 (8 days prior).   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: The follow up document was received and had  significant information. Added second dose details. Added race and ethnicity of patient  and vaccine facility information.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: The vial had been punctured on 01Sep2021 and out for 24-36 hours at room temperature.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (The vial had been punctured on 01Sep2021 and out for 24-36 hours at room temperature.) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     The patient's past medical history included Liver transplantation on 30-Jul-2012. Concurrent medical conditions included Drug allergy (Allergic to Tramodol), Chronic kidney disease since 02-Feb-2015 and Hypertension since 11-Jan-2017. Concomitant products included TACROLIMUS (PROGRAF) from 30-Jul-2012 to an unknown date for Chronic kidney disease, AMLODIPINE from 04-Jun-2018 to an unknown date and CARVEDILOL (COREG) from 15-Dec-2020 to an unknown date for Hypertension, ZOLPIDEM TARTRATE (AMBIEN) from 29-Sep-2016 to an unknown date for Insomnia.    On 02-Sep-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Sep-2021, the patient experienced PRODUCT STORAGE ERROR (The vial had been punctured on 01Sep2021 and out for 24-36 hours at room temperature.). On 02-Sep-2021, PRODUCT STORAGE ERROR (The vial had been punctured on 01Sep2021 and out for 24-36 hours at room temperature.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The treatment information was not provided. The race of the patient was reported as black. The reporter reported that the vial was opened on 01-SEP-2021 and was administered on 02-SEP-2021 .The vial was out at room temperature for about 24-36 hours. There was no temperature excursion reported. One dose was administered to the patient and remaining six doses were not administered to any patient.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow-up information received Include Patient Race, Ethnicity, medical history and concomitant medication.
Sex: U
Vaccine: COVID19
Symptoms: Formication
Clinical narrative: Feeling like something is crawling in my right ear; This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (Feeling like something is crawling in my right ear) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FORMICATION (Feeling like something is crawling in my right ear). At the time of the report, FORMICATION (Feeling like something is crawling in my right ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants were not provided. Treatment was not given.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 2nd dose administered to patient from expired vial/Above vaccine given at 7:30am on 9/1/21 and vaccine expired on 8/31/21. no adverse reaction noted. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from expired vial/Above vaccine given at 7:30am on 9/1/21 and vaccine expired on 8/31/21. no adverse reaction noted.) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Sep-2021 at 7:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from expired vial/Above vaccine given at 7:30am on 9/1/21 and vaccine expired on 8/31/21. no adverse reaction noted.). On 01-Sep-2021, EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from expired vial/Above vaccine given at 7:30am on 9/1/21 and vaccine expired on 8/31/21. no adverse reaction noted.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were provided.  No treatment information was mentioned.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow up received on 07-SEP-2021 contains No New Information
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 2nd dose administered to patient from expired vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from expired vial) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Aug-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from expired vial). On 01-Sep-2021, EXPIRED PRODUCT ADMINISTERED (2nd dose administered to patient from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  No Treatment information was provided.  Patient did not experience any adverse event.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Patient demographics, vaccine facility information and dose details like route and anatomical location were updated On 07-Sep-2021: No new information
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Influenza
Clinical narrative: Sick a little bit; Like a flu for the first 2 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick a little bit) and INFLUENZA (Like a flu for the first 2 days) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jul-2021, the patient experienced ILLNESS (Sick a little bit) and INFLUENZA (Like a flu for the first 2 days). On 27-Jul-2021, ILLNESS (Sick a little bit) and INFLUENZA (Like a flu for the first 2 days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications were not reported.  Treatment include Migraine medication.  Patient reported that she received second dose on 22 Aug 2021 on her left arm (lot 053E21A).   This case was linked to MOD-2021-306705.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Lymph node pain, Lymphadenopathy, Malaise, Myalgia
Clinical narrative: is uncomfortable; uncomfortable; big bubble of swelling under their right arm, on the lymph nodes; tender lymph nodes; felt kind of feverish, but with no temperature; achy; felt a little sluggish; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (felt a little sluggish), MALAISE (is uncomfortable), DISCOMFORT (uncomfortable), MYALGIA (achy) and LYMPHADENOPATHY (big bubble of swelling under their right arm, on the lymph nodes) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020K21A, 007M20A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Systemic lupus erythematosus (immunosuppressed since the patient have Lupus) and Immunosuppression. Concomitant products included LOSARTAN, LEVOTHYROXINE, RABEPRAZOL [RABEPRAZOLE], MONTELUKAST, ATORVASTATIN, FAMOTIDINE and CICLOSPORIN (RESTASIS) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Aug-2021, the patient experienced SLUGGISHNESS (felt a little sluggish) and PYREXIA (felt kind of feverish, but with no temperature). 30-Aug-2021, the patient experienced MYALGIA (achy). On 31-Aug-2021, the patient experienced MALAISE (is uncomfortable), LYMPHADENOPATHY (big bubble of swelling under their right arm, on the lymph nodes) and LYMPH NODE PAIN (tender lymph nodes). 31-Aug-2021, the patient experienced DISCOMFORT (uncomfortable). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, SLUGGISHNESS (felt a little sluggish), MALAISE (is uncomfortable), DISCOMFORT (uncomfortable), MYALGIA (achy) and PYREXIA (felt kind of feverish, but with no temperature) outcome was unknown and LYMPHADENOPATHY (big bubble of swelling under their right arm, on the lymph nodes) and LYMPH NODE PAIN (tender lymph nodes) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No lab investigations were provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Sluggishness
Clinical narrative: is uncomfortable; uncomfortable; big bubble of swelling under their right arm, on the lymph nodes; tender lymph nodes; felt kind of feverish, but with no temperature; achy; felt a little sluggish; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (felt a little sluggish), MALAISE (is uncomfortable), DISCOMFORT (uncomfortable), MYALGIA (achy) and LYMPHADENOPATHY (big bubble of swelling under their right arm, on the lymph nodes) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020K21A, 007M20A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Systemic lupus erythematosus (immunosuppressed since the patient have Lupus) and Immunosuppression. Concomitant products included LOSARTAN, LEVOTHYROXINE, RABEPRAZOL [RABEPRAZOLE], MONTELUKAST, ATORVASTATIN, FAMOTIDINE and CICLOSPORIN (RESTASIS) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Aug-2021, the patient experienced SLUGGISHNESS (felt a little sluggish) and PYREXIA (felt kind of feverish, but with no temperature). 30-Aug-2021, the patient experienced MYALGIA (achy). On 31-Aug-2021, the patient experienced MALAISE (is uncomfortable), LYMPHADENOPATHY (big bubble of swelling under their right arm, on the lymph nodes) and LYMPH NODE PAIN (tender lymph nodes). 31-Aug-2021, the patient experienced DISCOMFORT (uncomfortable). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, SLUGGISHNESS (felt a little sluggish), MALAISE (is uncomfortable), DISCOMFORT (uncomfortable), MYALGIA (achy) and PYREXIA (felt kind of feverish, but with no temperature) outcome was unknown and LYMPHADENOPATHY (big bubble of swelling under their right arm, on the lymph nodes) and LYMPH NODE PAIN (tender lymph nodes) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No lab investigations were provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very sore arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (very sore arm). At the time of the report, PAIN IN EXTREMITY (very sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took concomitant medications of Antidepressants. No treatment medications were provided by reporter.   This case was linked to MOD-2021-306642 (Patient Link).
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder pain/ the pain in his shoulder is still there/ his left shoulder hurts, around he deltoid muscle) and MYALGIA (muscle pain) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052C21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (shoulder pain/ the pain in his shoulder is still there/ his left shoulder hurts, around he deltoid muscle) and MYALGIA (muscle pain). At the time of the report, ARTHRALGIA (shoulder pain/ the pain in his shoulder is still there/ his left shoulder hurts, around he deltoid muscle) had not resolved and MYALGIA (muscle pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medication was reported. Patient has not taken any medication just applied some ice on it.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.            Concomitant medications were not reported. Treatment medications were not reported   This case was linked to MOD21-138908, MOD21-138909 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: covid 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid 19) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included RITUXIMAB (RITUXAN) for an unknown indication.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In June 2021, the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) does not have antibodies.         The treatment history was not reported. patient said "the vaccine didn't work on me" and asked for any information on what to do next. Patient wanted to know how to be protected against COVID-19.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: felt yuck/like how she felt when she gets her flu shot every year/didn't have this much of bad feelings; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt yuck/like how she felt when she gets her flu shot every year/didn't have this much of bad feelings) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Previously administered products included for Flu: flu shot (she gets her flu shot every year.). Concurrent medical conditions included Hypertension (She takes her daily dose for blood pressure and has been taking that for a long time.). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and GABAPENTIN (NEURONTIN) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt yuck/like how she felt when she gets her flu shot every year/didn't have this much of bad feelings). At the time of the report, FEELING ABNORMAL (felt yuck/like how she felt when she gets her flu shot every year/didn't have this much of bad feelings) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported that she had been taking blood pressure and female hormone medicine which were considered as concomitant drugs.  No treatment medication was reported by patient. Patient reported she was not immunocompromised.   This case was linked to MOD-2021-306735, MOD-2021-306741 (Patient Link).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: felt yuck/like how she felt when she gets her flu shot every year/didn't have this much of bad feelings; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt yuck/like how she felt when she gets her flu shot every year/didn't have this much of bad feelings) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 037K20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and GABAPENTIN (NEURONTIN) for Blood pressure.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt yuck/like how she felt when she gets her flu shot every year/didn't have this much of bad feelings). At the time of the report, FEELING ABNORMAL (felt yuck/like how she felt when she gets her flu shot every year/didn't have this much of bad feelings) outcome was unknown.            No treatment medication were provided by the reporter.  Concomitant medication included: female hormone.   This case was linked to MOD-2021-306715 (Patient Link).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Feeling abnormal, Influenza like illness, Malaise, Pyrexia
Clinical narrative: Not well; Feels like having a flu; Feels a bit of temperature; Received Moderna booster/ She is not immunocompromised; Feels yuck/ Feeling worse today; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feels yuck/ Feeling worse today), MALAISE (Not well), INFLUENZA LIKE ILLNESS (Feels like having a flu), PYREXIA (Feels a bit of temperature) and EXTRA DOSE ADMINISTERED (Received Moderna booster/ She is not immunocompromised) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A, 037K20A and 043L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and GABAPENTIN (NEURONTIN) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Sep-2021, the patient experienced FEELING ABNORMAL (Feels yuck/ Feeling worse today) and EXTRA DOSE ADMINISTERED (Received Moderna booster/ She is not immunocompromised). On an unknown date, the patient experienced MALAISE (Not well), INFLUENZA LIKE ILLNESS (Feels like having a flu) and PYREXIA (Feels a bit of temperature). On 02-Sep-2021, EXTRA DOSE ADMINISTERED (Received Moderna booster/ She is not immunocompromised) had resolved. At the time of the report, FEELING ABNORMAL (Feels yuck/ Feeling worse today), MALAISE (Not well), INFLUENZA LIKE ILLNESS (Feels like having a flu) and PYREXIA (Feels a bit of temperature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported of consuming female hormone, daily dose for blood pressure (had been taking that for a long time), baby aspirin and Neurontin at night.  Patient wanted to know if Tylenol or Ibuprofen can be taken.   This case was linked to MOD-2021-306735, MOD-2021-306715.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Patient lost taste for a week; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Patient lost taste for a week) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Patient lost taste for a week). At the time of the report, AGEUSIA (Patient lost taste for a week) had resolved.            Concomitant product was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Scheduled to have a surgery; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Scheduled to have a surgery) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Scheduled to have a surgery). At the time of the report, VACCINATION COMPLICATION (Scheduled to have a surgery) outcome was unknown.      No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter
Sex: U
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: Exposed to someone who might have been re-infected with virus; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Exposed to someone who might have been re-infected with virus) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (Exposed to someone who might have been re-infected with virus). At the time of the report, SUSPECTED COVID-19 (Exposed to someone who might have been re-infected with virus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were reported.   Reporter did not allow further contact
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: bad chills; pretty sure he had a fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (bad chills) and PYREXIA (pretty sure he had a fever) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced PYREXIA (pretty sure he had a fever). On 02-Sep-2021 at 2:00 AM, the patient experienced CHILLS (bad chills). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, CHILLS (bad chills) and PYREXIA (pretty sure he had a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No  Concomitant medications were provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered to patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Sep-2021 at 7:40 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: is very sick; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (is very sick) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced VACCINATION COMPLICATION (is very sick). At the time of the report, VACCINATION COMPLICATION (is very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products, Off label use
Clinical narrative: Patient age 14 received dose of Moderna; Patient received first dose of Pfizer on 29-JUL-2021 and second dose of Moderna COVID 19 vaccine on 02-SEP-2021; Patient received first dose of Pfizer and second dose of Moderna COVID 19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of OFF LABEL USE (Patient age 14 received dose of Moderna), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose of Pfizer on 29-JUL-2021 and second dose of Moderna COVID 19 vaccine on 02-SEP-2021) and INTERCHANGE OF VACCINE PRODUCTS (Patient received first dose of Pfizer and second dose of Moderna COVID 19 vaccine) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.    Co-suspect product included non-company product BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 29-Jul-2021, the patient received first dose of BNT162B2                                                                                              (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 02-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced OFF LABEL USE (Patient age 14 received dose of Moderna), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose of Pfizer on 29-JUL-2021 and second dose of Moderna COVID 19 vaccine on 02-SEP-2021) and INTERCHANGE OF VACCINE PRODUCTS (Patient received first dose of Pfizer and second dose of Moderna COVID 19 vaccine). On 02-Sep-2021, OFF LABEL USE (Patient age 14 received dose of Moderna), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose of Pfizer on 29-JUL-2021 and second dose of Moderna COVID 19 vaccine on 02-SEP-2021) and INTERCHANGE OF VACCINE PRODUCTS (Patient received first dose of Pfizer and second dose of Moderna COVID 19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided Treatment information was not reported  It was reported that clinic gave a pediatric patient a Moderna vaccine when patient should have been give Pfizer (as their second dose).   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Follow-up document received; Updated vaccine facility information.